Mast Therapeutics (NYSE: MSTX) 22.6% LOWER; On July 25, 2016, Mast Therapeutics provided guidance on the anticipated timing for announcement ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Needham & Company Reiterates Buy as Sanmina (SANM) Shares Sell Off; Sees Weakness as Buying Opportunity July 27, 2016 3:37 PM Jefferies Remains Sidelined on Gilead Sciences (GILD) Following 2Q - PT to $93 July 26, 2016 9:15 AM UBS Raises price Target on Texas Instruments (TXN) to $76; Reiterates Buy July 26, 2016 8:57 AM Mizuho Securities Raises Price Target on Texas Instruments (TXN) to $65 Following 2Q July 26, 2016 7:31 AM RBC Capital Reiterates Sector Perform on Sanmina (SANM) Following In-Line 3Q July 26, 2016 7:09 AM